Correction: FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells

Oncotarget. 2019 Dec 10;10(65):7014-7015. doi: 10.18632/oncotarget.27353.

Ming Zhao¹, Ming-Lei Zhuo², Xiaofeng Zheng³, Xiaoping Su³, Funda Meric-Bernstam^{1

4

5}

¹ Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Key Laboratory of Carcinogenesis and Translational Research, Department of Thoracic Medical Oncology-I, Peking University Cancer Hospital and Institute, Beijing, China.
³ Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Institute of Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.26530.].